162 related articles for article (PubMed ID: 25662039)
1. No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study.
Tsikas D; Pham VV; Suchy MT; van de Ree MA; Huisman MV; Frölich JC; Princen HM;
Pharmacol Res; 2015 Apr; 94():1-8. PubMed ID: 25662039
[TBL] [Abstract][Full Text] [Related]
2. Results, meta-analysis and a first evaluation of U
Tsikas D; Hanff E; Bollenbach A; Kruger R; Pham VV; Chobanyan-Jürgens K; Wedekind D; Arndt T; Jörns A; Berbée JFP; Princen HMG; Lücke T; Mariotti F; Huneau JF; Ückert S; Frölich JC; Lenzen S
Amino Acids; 2018 Jul; 50(7):799-821. PubMed ID: 29728915
[TBL] [Abstract][Full Text] [Related]
3. The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus.
Carmann C; Lilienthal E; Weigt-Usinger K; Schmidt-Choudhury A; Hörster I; Kayacelebi AA; Beckmann B; Chobanyan-Jürgens K; Tsikas D; Lücke T
Amino Acids; 2015 Sep; 47(9):1865-74. PubMed ID: 26123986
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
5. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications.
Hishinuma T; Tsukamoto H; Suzuki K; Mizugaki M
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):191-6. PubMed ID: 11728171
[TBL] [Abstract][Full Text] [Related]
6. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir.
Schneider JY; Rothmann S; Schröder F; Langen J; Lücke T; Mariotti F; Huneau JF; Frölich JC; Tsikas D
Amino Acids; 2015 Sep; 47(9):1961-74. PubMed ID: 26123989
[TBL] [Abstract][Full Text] [Related]
8. Effects of paracetamol on NOS, COX, and CYP activity and on oxidative stress in healthy male subjects, rat hepatocytes, and recombinant NOS.
Trettin A; Böhmer A; Suchy MT; Probst I; Staerk U; Stichtenoth DO; Frölich JC; Tsikas D
Oxid Med Cell Longev; 2014; 2014():212576. PubMed ID: 24799980
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease.
Stichtenoth DO; Kreutzer FJ; Gutzki FM; Tsikas D; Nowak V; Frölich JC
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):211-4. PubMed ID: 11728174
[TBL] [Abstract][Full Text] [Related]
10. [A relationship between insulin resistance and reduction in oxidative stress in vivo by atorvastatin].
Hitsumoto T; Iizuka T; Takahashi M; Nakamura K; Shimizu K; Satoh S; Sugiyama Y; Sakurai T; Noike H; Ohsawa H; Watanabe H; Shirai K
J Cardiol; 2004 Dec; 44(6):233-42. PubMed ID: 15638221
[TBL] [Abstract][Full Text] [Related]
11. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
Scand J Clin Lab Invest; 2014 Jan; 74(1):8-19. PubMed ID: 24256611
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.
Mason RP; Corbalan JJ; Jacob RF; Dawoud H; Malinski T
J Physiol Pharmacol; 2015 Feb; 66(1):65-72. PubMed ID: 25716966
[TBL] [Abstract][Full Text] [Related]
14. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
15. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C
Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus.
Su Y; Xu Y; Sun YM; Li J; Liu XM; Li YB; Liu GD; Bi S
J Cardiovasc Pharmacol; 2010 Jan; 55(1):21-5. PubMed ID: 19786892
[TBL] [Abstract][Full Text] [Related]
17. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
Schwedhelm E; Bartling A; Lenzen H; Tsikas D; Maas R; Brümmer J; Gutzki FM; Berger J; Frölich JC; Böger RH
Circulation; 2004 Feb; 109(7):843-8. PubMed ID: 14757688
[TBL] [Abstract][Full Text] [Related]
18. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
Helmersson J; Vessby B; Larsson A; Basu S
Circulation; 2004 Apr; 109(14):1729-34. PubMed ID: 15037525
[TBL] [Abstract][Full Text] [Related]
19. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
Santilli F; Bucciarelli L; Noto D; Cefalù AB; Davì V; Ferrante E; Pettinella C; Averna MR; Ciabattoni G; Davì G
Free Radic Biol Med; 2007 Nov; 43(9):1255-62. PubMed ID: 17893038
[TBL] [Abstract][Full Text] [Related]
20. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin.
Yamamoto T; Cohen AM; Kakar NR; Yamamoto M; Johnson PE; Cho YK; Bing RJ
Biochem Biophys Res Commun; 1999 Apr; 257(2):488-93. PubMed ID: 10198239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
